Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|December 3, 2011
Voltage-gated calcium channels and Parkinson's diseaseMichael J Hurley, David T Dexter
The European Journal of Neuroscience|November 19, 2003
Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCRMichael J Hurley, Deborah C Mash, Peter Jenner
Journal of Alzheimer'S Disease : JAD|September 11, 2023
Many Paths to Alzheimer's Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk FactorsDonald J Lehmann, Amany Elshorbagy, Michael J Hurley
Journal of Molecular Neuroscience : MN|September 1, 2014
Calcium CaV1 channel subtype mRNA expression in Parkinson's disease examined by in situ hybridizationMichael J Hurley, Steve M Gentleman, David T Dexter
Brain : a Journal of Neurology|June 18, 2013
Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteinsMichael J Hurley, Bianca Brandon, Steve M Gentleman, et al.
Pharmacology & Therapeutics|November 18, 2022
Bile acids and neurological diseaseMichael J Hurley, Rachel Bates, Jane Macnaughtan, et al.
Journal of Molecular Neuroscience : MN|October 24, 2013
Proteomic analysis of striatum from MPTP-treated marmosets (Callithrix jacchus) with L-DOPA-induced dyskinesia of differing severityMichael J Hurley, Michael J Jackson, Lance A Smith, et al.
NPJ Parkinson'S Disease|July 27, 2023
Neuroprotective role for RORA in Parkinson's disease revealed by analysis of post-mortem brain and a dopaminergic cell lineFelwah S Al-Zaid, Michael J Hurley, David T Dexter, et al.
Journal of Molecular Neuroscience : MN|May 19, 2015
Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson's DiseaseMichael J Hurley, Pascal F Durrenberger, Steve M Gentleman, et al.
Pageof 2